Beacon Microbiome Database Summary
- Unrivalled comprehensive & accurate preclinical and clinical Microbiome drug, trial and commercial data.
- Access to 1,000+ Drugs, 800+ Trials, 850+ Companies, and 650+ Deals in the Microbiome space
- Market leading ontologies, enabling precise navigation of the Microbiome drug development landscape
- Manually curated by Microbiome scientists, with data updated daily
- Your one stop shop for Microbiome targeted therapy intelligence data

Why Beacon Microbiome Database?
How Beacon Microbiome Database Can Help You?
Run the most comprehensive microbiome drug & trial searches using manually curated searching filters based on microbiome technologies including donor source, consortia growth conditions, editing technology, microbiome target factor, microbiome therapy engineering, microbiome therapy type, role of phage & species, allowing you to assess where competitive threats lie or where gaps in the market present a new opportunity
Benchmark your preclinical microbiome research with confidence by accessing more preclinical microbiome data than anywhere else., spread across curated in vitro, efficacy, toxicity & PK data released for every microbiome program in one place, allowing you to compare every readout against the wider field
Track clinical microbiome developments through to approvals with a market leading curation approach, segmenting clinical readouts into drug dosing, patient data, toxicity & results, with 100s of conferences curated & over 40,000 sources monitored daily
Optimize your microbiome partnership strategy by identifying new prospect companies or competitors as soon as they enter the field, taking advantage of Beacon’s deal & company data with a unique approach to capturing early-stage companies and curated insights on deals & pipelines all in one place for a given technology
Arm yourself with robust landscape data for drugs & trials that compete with your asset, being able to leverage scientific readouts from Beacon’s curated data & assess the commercial landscape with all microbiome company profiles & deals captured in one place
Beacon Microbiome Database: The Numbers
Beacon Microbiome Database: Key Data Segments
Drug Data
Revolutionize your searching of the Microbiome drug development landscape.
Utilize >20 search filters to find programs based on disease indication, drug modality, species, Microbiome Target Factor and Microbiome Therapy Type, and many more.
Trial Data
Optimize your Microbiome clinical trial design searching capabilities.
Seamlessly benchmark clinical trial results and search the Microbiome trial landscape based on drug technologies, combination trials, trial locations, trial phase, disease indication and more.
Milestones
A unique Microbiome drug development milestone filter and visualization tool.
Track past, present, and future Microbiome drug development milestones, including drug and trial readouts, asset history, and regulatory announcements.
Company Data
Your centralized location for Microbiome company intelligence
Identify competitors and business development opportunities, using unique company filters including, company type, HQ locations, operating status & latest funding round, and technologies / diseases targeted in their pipeline.
Deal Data
De-risk your Microbiome drug development partnership & fundraising projects
Search Microbiome drug development deals using custom search filters based on drug technologies involved, deal value & upfront payments, deal types to filter M&As, financing & partnership / licensing deals, geographic market, funding type, and many more.
Beacon Microbiome Database: Drug Modalities
Analyze 1,000 + drugs (preclinical and clinical) and 800 + clinical trials (from early to late stage).
Beacon Microbiome covers all engineered and non-engineered microbiome-based therapeutic assets for all human disease indications.
Therapies include:
- Live Biotherapeutics
- Whole Ecosystem Derived Products
- Inactivated Microbes
- Bacteriophage
- Microbiome Targeting Molecules
- Microbiome Sourced Molecules
Beacon Microbiome also includes a host of preclinical data including, cell line and animal model experimental data.
Who is Beacon Microbiome Database For?
Beacon Microbiome is a manually curated database of comprehensive, high quality, and accurate, preclinical and clinical drug, trial and commercial data, offering unrivalled insight into the Microbiome drug development landscape.
Scientific Strategy Leader
Select the right pipeline for your Microbiome drug development
Research Scientist
Validate new targets & inform your Microbiome-based therapy design
Clinical Development
Design optimized Microbiome-based therapy clinical trials & benchmark against the competition
Business Development
Uncover new Microbiome-based therapy licensing, partnership and fundraising opportunities
Competitive Intelligence
Track competitive threats & emerging Microbiome technologies
Translational Development
Confidently take your preclinical Microbiome-based therapy into the clinic
Related Resources
Check out Microbiome related resources available from Beacon
Our Experts

Ada Lam
Lead Research Analyst

Charlie De Lanoy Meijer
Account Manager

Frank Plowden
Account Manager
Hanson Wade Events
Check out the upcoming events from Hanson Wade